Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adipose tissue lipid synthesis enzymes are a group of proteins that catalyze the formation and storage of lipids (primarily triglycerides) in adipocytes. Key enzymes include Acyl-CoA:Diacylglycerol Acyltransferase (DGAT), Fatty Acid Synthase (FAS), and Lipoprotein Lipase (LPL). These enzymes play central roles in energy homeostasis, metabolic health, and the regulation of whole-body lipid metabolism. Alterations or mutations affecting these enzymes have been linked to obesity, insulin resistance and represent potential targets for metabolic therapies.
Varied, depending on the specific enzyme targeted. Examples include inhibition of DGAT, FAS, or modulation of LPL activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adipose Tissue Lipid Synthesis Enzymes (None).